Journal article icon

Journal article

Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.

Abstract:

Although statins significantly decrease the incidence of cardiovascular disease (CVD), residual CVD risk remains high. This may partly be due to uncorrected atherogenic dyslipidaemia. The driving force behind atherogenic dyslipidaemia is hypertriglyceridaemia, which results from hepatic oversecretion and/or hypocatabolism of triglyceride-rich lipoproteins, and is typical of type 2 diabetes and metabolic syndrome. Persistent atherogenic dyslipidaemia in patients treated with a statin according...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/pgmj.2010.204990rep

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM, Biomedical Research Centre
Role:
Author
Journal:
Postgraduate medical journal
Volume:
87
Issue:
1033
Pages:
776-782
Publication date:
2011-11-05
DOI:
EISSN:
1469-0756
ISSN:
0032-5473
URN:
uuid:3574183e-6c65-430f-95a5-8ed29c065702
Source identifiers:
198770
Local pid:
pubs:198770
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP